Randomized experiment

1 Basics of Randomized Experiments

1.1 Definition and key idea of random assignment

A randomized experiment is a study in which participants are assigned to one or more conditions by a chance mechanism. The core idea is that randomness, applied at the assignment stage, tends to equalize observed and unobserved characteristics across groups on average. As a result, differences in outcomes can be interpreted as consequences of the treatment rather than the result of systematic selection.

1.2 Experimental units and treatment conditions

An experimental unit is the entity assigned to a condition. Units may be individuals, households, schools, devices, or user accounts, depending on the research context. Treatment conditions represent the options under comparison, such as a new product feature versus a standard feature, or a teaching method versus business-as-usual practice.

1.3 What makes it “randomized” (randomization mechanisms)

Randomization refers to the use of a probabilistic rule that determines assignments independently of participants’ characteristics. This rule can be implemented by random number generators, shuffled lists, or controlled procedures that yield approximately equal chances across conditions (or across strata, when stratification is used). The defining feature is that the assignment process cannot be reliably predicted by those enrolling participants.

1.4 Common comparison goals (difference in outcomes, effect size)

Randomized experiments commonly aim to quantify how an intervention changes outcomes. Analysts often focus on contrasts between conditions, such as the difference in average outcomes or the ratio of response rates. These contrasts can be summarized as an effect size, providing a scale and direction for the treatment’s impact. In many studies, the primary goal is the average effect across all participants, while secondary goals explore subgroup patterns or time-dependent effects.

2 Design and Planning

2.1 Choosing the treatment and control groups

2.1.1 Active control vs placebo vs no-treatment

Control conditions establish what the treatment is being compared against. An active control uses an alternative active intervention that resembles the treatment in key logistics, helping isolate the specific component under study. A placebo is an inert substitute designed to mirror the treatment experience without delivering the active element. No-treatment (or usual practice) comparisons evaluate changes relative to the absence of an added intervention.

2.2 Selecting outcomes and measurement timing

Outcomes are the measurable responses used to evaluate success, such as symptom scores, performance metrics, engagement measures, or satisfaction ratings. Measurement timing should reflect when effects are expected to emerge, while also accounting for follow-up windows, potential latency, and the risk of observing too early or too late to capture meaningful change. Pre-specifying outcomes and time points reduces the chance of selective reporting.

2.3 Determining sample size and power

Sample size planning balances feasibility with statistical precision. Power reflects the probability of detecting a specified effect size under assumed variability and event rates. Calculations often use prior knowledge from prior studies, pilot data, or plausible effect ranges. Underpowered studies may fail to detect real effects, while overly large studies can be inefficient.

2.4 Randomization scheme selection

2.4.1 Simple randomization

Simple randomization assigns units to conditions using equal probability across groups. It is straightforward and can perform well when sample size is moderate to large. However, with small samples, chance imbalances in baseline characteristics can occur more frequently.

2.4.2 Block randomization

Block randomization divides enrollment into blocks and assigns within each block so that treatment group sizes remain balanced as participants are recruited. This approach can be useful in settings where enrollment occurs over time, helping maintain comparable group sizes and improving balance when sample size is limited.

2.4.3 Stratified randomization

Stratified randomization first groups participants by one or more baseline variables (strata), then randomizes within each stratum. This can reduce imbalance for key prognostic factors. The trade-off is complexity: more strata can require larger sample sizes to avoid sparse combinations.

2.5 Pre-registration and analysis plans (when applicable)

An analysis plan specifies primary outcomes, statistical methods, and decision rules in advance. Pre-registration is particularly helpful for studies where selective analysis could bias conclusions. Even when formal pre-registration is not used, clearly documented planning supports transparency and interpretability.

3 Implementation and Fidelity

3.1 Allocation concealment and preventing bias

Allocation concealment refers to procedures that prevent foreknowledge of upcoming assignments. If recruiters or participants can predict group membership, enrollment may become nonrandom in practice. Concealment often relies on centralized assignment systems, sealed procedures, or secure randomization tools.

3.2 Blinding and masking strategies

Blinding aims to prevent participants, investigators, or outcome assessors from knowing condition assignments. In trials involving subjective outcomes, masking can reduce expectation effects. Some studies cannot fully blind participants, but partial blinding—such as keeping assessors unaware—may still help reduce measurement bias.

3.3 Ensuring protocol adherence

Fidelity concerns whether participants receive or experience the assigned condition as intended. Operational steps—training, checklists, automated controls, and monitoring—reduce deviations. Adherence also includes maintaining consistent measurement procedures across groups.

3.4 Handling crossovers and noncompliance

Crossovers occur when participants switch from their assigned condition to another before outcomes are measured. Noncompliance includes failures to receive the intended treatment, such as opting out or failing to use an assigned feature. Analyses often address these issues using frameworks that preserve the benefits of random assignment, while also acknowledging that real-world implementation may dilute effects.

3.5 Tracking and managing missing data

Missing data can arise from dropout, technical failures, or nonresponse. Planning should include strategies to track missingness patterns and, where appropriate, use statistical methods that incorporate uncertainty. Because randomization does not guarantee complete data, handling missing outcomes is central to maintaining valid inference.

4 Statistical Analysis

4.1 Estimating treatment effects

4.1.1 Average treatment effect (ATE)

The average treatment effect represents the expected difference in outcomes between treated and untreated conditions, averaged across the population of interest. In randomized experiments, estimators of ATE often compare group means or proportions, leveraging random assignment to interpret the difference causally under standard assumptions.

4.1.2 Intention-to-treat vs per-protocol

Intention-to-treat analysis compares participants according to their assigned groups, regardless of compliance. This preserves the randomization structure and provides a robust estimate of the effect of assignment or offering treatment. Per-protocol analysis restricts to participants who followed the protocol as intended; while it may estimate a “treatment received” effect, it can introduce bias if adherence is related to outcomes.

4.2 Regression and adjustment (when appropriate)

Regression models can improve precision and help handle covariate imbalance, especially when outcomes are continuous, binary, or time-to-event. In randomized settings, including baseline covariates can reduce variance without undermining causal interpretation, provided randomization remains intact and models are specified carefully.

4.3 Confidence intervals and uncertainty quantification

Confidence intervals communicate the plausible range of the treatment effect given the data and model assumptions. They are often preferred over single-point estimates because they convey uncertainty and allow comparison across studies. Interval width is influenced by sample size, outcome variability, and effect magnitude.

4.4 Hypothesis testing in randomized settings

Hypothesis tests evaluate whether observed differences are likely to arise by chance under a null hypothesis of no treatment effect. Although p-values provide one way to summarize evidence, randomized experiments also rely on effect size and interval estimates to assess practical importance.

4.5 Multiple comparisons and correction approaches

When multiple outcomes, subgroups, or time points are analyzed, the probability of false positives increases. Correction methods, such as controlling the familywise error rate or the false discovery rate, can mitigate this risk. Pre-specifying primary endpoints and limiting exploratory comparisons reduces the need for aggressive correction.

5 Assumptions, Validity, and Diagnostics

5.1 Randomization checks (baseline balance)

Randomization checks evaluate whether baseline characteristics are similar across conditions. While these checks cannot prove groups are identical, large imbalances can indicate implementation problems, broken concealment, or sample-specific issues. Balance assessments often use standardized differences rather than relying solely on hypothesis tests.

5.2 Interference and spillover considerations (conceptual)

Interference occurs when one participant’s outcome is affected by another participant’s assigned condition. In many settings, spillovers are minimal, but they can arise through social networks, shared environments, or indirect exposure to changes. When interference is plausible, standard methods may need adaptation, and causal interpretations become more nuanced.

5.3 Internal validity vs external validity

Internal validity concerns whether the study supports causal conclusions about the treatment effect within the study context. External validity concerns whether results generalize to broader populations or settings. Randomization strengthens internal validity, while external validity depends on participant representativeness, treatment implementation, and measurement comparability.

5.4 Robustness and sensitivity analyses

Robustness checks explore whether conclusions change under alternative assumptions or modeling choices. Sensitivity analyses assess how much results would need to shift to overturn primary conclusions, particularly in the presence of missing data, noncompliance, or plausible deviations from idealized assumptions.

5.5 Assessing effect heterogeneity

Effect heterogeneity examines whether the treatment effect differs across subgroups, such as by baseline risk, demographic characteristics, or usage patterns. While heterogeneity can provide useful insights, it is also prone to spurious findings if many subgroup analyses are conducted. Careful pre-specification and adequate sample sizes are important.

6 Special Types of Randomized Experiments

6.1 Cluster randomized experiments

6.1.1 Unit-of-randomization vs unit-of-analysis

In cluster randomized experiments, whole groups (clusters) are assigned to conditions, such as classrooms, clinics, or online communities. This design recognizes that participants within a cluster may influence one another, violating independence assumptions. Analysis must account for clustering by treating observations as correlated within clusters, often using cluster-level variance estimation.

6.2 Factorial experiments

6.2.1 Main effects and interaction effects

Factorial designs randomize participants to combinations of multiple treatments, enabling estimation of each treatment’s main effect and potential interaction effects. The interaction term captures whether the impact of one intervention depends on the presence or level of another. Factorial experiments can increase efficiency by learning more in a single study relative to running separate experiments.

6.3 Crossover and repeated-measures designs

Crossover designs expose participants to multiple conditions across different periods, allowing within-person comparisons. Repeated-measures designs collect outcome data multiple times, capturing dynamics rather than a single snapshot. These designs often require careful handling of period effects, carryover between conditions, and time-varying confounders related to the order of exposure.

6.4 Adaptive randomization and platform experiments

Adaptive randomization adjusts assignment probabilities based on accumulating data. In platform settings, this may help allocate more traffic to better-performing options over time. Proper design ensures that the adaptation does not introduce bias and that uncertainty quantification remains valid, often requiring specialized inference methods.

6.5 Stepped-wedge and phased rollout designs (conceptual)

Stepped-wedge and phased rollout approaches introduce the intervention to different groups at different times, allowing comparisons between early and later rollout cohorts. These designs can be helpful when an intervention cannot be simultaneously deployed. Conceptually, they rely on separating treatment effects from time trends, requiring assumptions about stability and careful analysis strategy.

7 Reporting and Interpretation

7.1 Reporting standards and transparency

Transparent reporting includes describing randomization methods, enrollment procedures, assignment concealment, blinding, adherence levels, and missing data handling. Reporting standards often call for a flow of participants through the study, along with summary statistics by condition.

7.2 Interpreting effect sizes in context

Interpretation should connect numerical estimates to real-world meaning. For example, a small increase in conversion rate may still be valuable at scale, while a modest effect on a primary clinical outcome may have different implications depending on baseline risk. Context also includes cost, burden, and feasibility of implementation.

7.3 Common pitfalls and misconceptions

Common issues include interpreting statistical significance as proof of importance, ignoring noncompliance, failing to account for clustered data, and concluding causality from observational comparisons. Another misconception is that any baseline balance guarantees validity; implementation failures can still occur while passing superficial balance checks.

7.4 Communicating uncertainty clearly

Uncertainty is communicated through confidence intervals, uncertainty ranges, and transparent discussion of assumptions. Good practice also includes acknowledging limitations that affect the strength of inference, such as measurement reliability, missing outcomes, and potential interference.

Reproducibility is supported by sharing analysis code, specifying software and versions, and providing documentation for derived variables. When privacy and consent permit, sharing de-identified data or summary datasets can help others verify results and build upon the findings.

8 Practical Experiments in Everyday Contexts

8.1 Small-scale A/B tests and usability studies

In everyday digital or service contexts, teams often run small A/B tests to compare alternative interfaces, wording, or workflows. Usability studies may combine experiments with qualitative feedback to understand why a change improves or harms user experience. Even small studies benefit from clear endpoints, consistent measurement, and careful handling of random assignment.

8.2 Randomized trials in education experiments (light overview)

Education experiments can use random assignment to compare teaching approaches, practice schedules, or learning tools. Outcomes may include test scores, completion rates, or engagement measures. Practical constraints often shape design choices, such as using randomization at the classroom level and accounting for clustered learning environments.

8.3 Randomization in app features and recommendation demos

Apps frequently test features by randomly exposing users to different versions, such as alternate notifications, recommendation ranking adjustments, or user interface themes. Randomization helps isolate the causal effect of the feature on engagement or retention, while monitoring for side effects like increased churn or unintended behavioral shifts.

8.4 Ethical considerations for benign interventions (non-controversial framing)

Ethical practice in benign experiments emphasizes respect, transparency appropriate to the setting, minimizing harm, and ensuring participants are not deprived of essential services. In consumer settings, experiments typically involve nonessential features or improvements, but ethical review still considers user experience, data handling, and the proportionality of testing.